Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil

Digit J Ophthalmol. 2022 Jun 27;28(8):34-37. doi: 10.5693/djo.02.2022.02.002. eCollection 2022.

Abstract

Netarsudil is a relatively new medication for the treatment of primary open-angle glaucoma and ocular hypertension. It has been associated with red eyes and burning after instillation. Reticular epitheliopathy is a relatively rare complication of netarsudil that has been described in patients with preexisting corneal edema. We report the case of a healthy 76-year-old woman who developed reticular epitheliopathy after full-thickness penetrating keratoplasty that completely resolved following discontinuation of the medication. In cases where netarsudil is initiated for treatment of glaucoma or, off-label, endothelial dysfunction, reticular epithelial edema should be considered in patients complaining of a decline in vision and severe pain.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Benzoates
  • Edema / complications
  • Female
  • Glaucoma* / etiology
  • Glaucoma, Open-Angle* / complications
  • Glaucoma, Open-Angle* / drug therapy
  • Glaucoma, Open-Angle* / surgery
  • Humans
  • Intraocular Pressure
  • Keratoplasty, Penetrating / adverse effects
  • beta-Alanine / analogs & derivatives

Substances

  • Benzoates
  • beta-Alanine
  • netarsudil